Project description required to be submitted to the speaker where the project receives financial assistance but the project is not required to be submitted for consideration to a Community Board, Borough Board or the City Council
Our audit found that not all of the Manhattan Community Boards complied with the City Charter requirements relating to public meetings and hearings and to maintaining websites.
This report is the second required annual report issued pursuant to Local Law 152 of 2018 and includes information related to putrescible transfer stations and non-putrescible transfer stations covered by LL152.
Report includes the number of employees assigned to each fire company and special operations unit, by gender and race or ethnicity, and the number of employees who reside within the immediate service area of each fire company, by gender and race or ethnicity.
Report includes the number of employees assigned to each fire company and special operations unit, by gender and race or ethnicity, and the number of employees who reside within the immediate service area of each fire company, by gender and race or ethnicity.
CCPC collects and retains various documents from the NYPD that contain identifying information. These documents are reviewed and analyzed in order for us to make recommendations and findings regarding the NYPD's anti-corruption systems.
The 2023 Proposed Consolidated Plan One-Year Action Plan (the “Proposed Action
Plan”) is the City of New York’s annual application to the United States Department of
Housing and Urban Development (HUD) for the four Office of Community Planning and Development entitlement programs.
The 2022 CAPER reports on New York City’s one-year progress (January 1, 2022, to December 31, 2022) in using its annual entitlement grants award to address the priority needs and goals articulated in the City’s Consolidated Five-Year Strategic Plan for plan years 2021-2025.
Report including (1) the number of opioid antagonists available; (2) the number of staff trained to administer; (3) the number of instances during the quarter it was administered; and (4) the number of instances in which the patient responded to the administration of an opioid antagonist.